Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMRN | Amarin Corporation Plc Sponsored ADR | -0.17% | 17.23 | 2.0% | $168.99m | |
| PRGO | Perrigo Co. Plc | 2.30% | 45.90 | 6.8% | $129.89m | |
| SAGE | SAGE Therapeutics, Inc. | 2.44% | 139.79 | 9.5% | $122.46m | |
| JAZZ | Jazz Pharmaceuticals Plc | 1.32% | 129.07 | 2.2% | $96.51m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | 2.07% | 137.29 | 6.3% | $79.66m | |
| PTLA | Portola Pharmaceuticals, Inc. | 3.59% | 26.53 | 7.7% | $62.96m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -0.19% | 113.45 | 18.6% | $56.62m | |
| MNK | Mallinckrodt Plc | 3.72% | 20.64 | 21.1% | $46.44m | |
| CTLT | Catalent Inc | 1.12% | 35.61 | 2.4% | $43.31m | |
| AXSM | Axsome Therapeutics, Inc. | -1.92% | 8.16 | 2.7% | $41.31m | |
| UTHR | United Therapeutics Corporation | 1.37% | 115.75 | 14.4% | $40.84m | |
| ICLR | ICON Plc | -0.18% | 133.18 | 4.1% | $40.29m | |
| ENDP | Endo International Plc | -1.52% | 9.70 | 8.9% | $37.43m | |
| HZNP | Horizon Pharma plc | -1.71% | 21.84 | 7.4% | $29.17m | |
| MDCO | Medicines Company | 0.25% | 20.00 | 21.8% | $28.86m |
Company Profile
SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.